Tae-Young Chung

Tae-Young Chung


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JKJaeryung Kim
Jaeryung Kim
DPDae-Young Park
Dae-Young Park
HBHosung Bae
Hosung Bae
DPDo Young Park
Do Young Park
DKDongkyu Kim
Dongkyu Kim
GKGou Young Koh
Gou Young Koh
Primary open-angle glaucoma (POAG) is often caused by elevated intraocular pressure (IOP), which arises due to increased resistance to aqueous humor outflow (AHO). Aqueous humor flows through Schlemm’s canal (SC), a lymphatic-like vessel encircling the cornea, and via intercellular spaces of ciliary muscle cells. However, the mechanisms underlying increased AHO resistance are poorly understood. Here, we demonstrate that signaling between angiopoietin (Angpt) and the Angpt receptor Tie2, which is critical for SC formation, is also indispensable for maintaining SC integrity during adulthood. Deletion of Angpt1/Angpt2 or Tie2 in adult mice severely impaired SC integrity and transcytosis, leading to elevated IOP, retinal neuron damage, and impairment of retinal ganglion cell function, all hallmarks of POAG in humans. We found that SC integrity is maintained by interconnected and coordinated functions of Angpt-Tie2 signaling, AHO, and Prox1 activity. These functions diminish in the SC during aging, leading to impaired integrity and transcytosis. Intriguingly, Tie2 reactivation using a Tie2 agonistic antibody rescued the POAG phenotype in Angpt1/Angpt2-deficient mice and rejuvenated the SC in aged mice. These results indicate that the Angpt-Tie2 system is essential for SC integrity. The impairment of this system underlies POAG-associated pathogenesis, supporting the possibility that Tie2 agonists could be a therapeutic option for glaucoma.

1 January 2014 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
GBGi Hyun Bae
Gi Hyun Bae
JKJaeryung Kim
Jaeryung Kim
CKChi Hoon Kim
Chi Hoon Kim
DLDong Hui Lim
Dong Hui Lim
ECEui Sang Chung
Eui Sang Chung
TCTae-Young Chung
Tae-Young Chung

1 November 2019 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
JCJae Hwan Choi
Jae Hwan Choi
DLDong Hui Lim
Dong Hui Lim
SNSeung Wan Nam
Seung Wan Nam
CYChan Min Yang
Chan Min Yang
ECEui Sang Chung
Eui Sang Chung
TCTae-Young Chung
Tae-Young Chung
To report the long-term clinical outcomes, including efficacy and safety, of implantable collamer lens (ICL) implantation to treat myopia. Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Retrospective case series. Medical records of patients who had ICL implantation were reviewed. The preoperative and postoperative visual acuity, spherical equivalent (SE), endothelial cell density (ECD), and intraocular pressure (IOP) were analyzed. The postoperative vault and complication rate, including cataract and glaucoma, were evaluated. Patients were placed in the lens opacity group or clear lens group based on whether lens opacity developed postoperatively. One hundred ten eyes (60 patients) were analyzed. The mean preoperative age was 30.3 years ± 8.3 (SD). The mean SE was -12.01 ± 3.70 diopters (D) preoperatively and -0.65 ± 1.09 D 10 years postoperatively. The mean vault height was 562.4 ± 175.9 μm 6 months postoperatively, decreasing to 352.9 ± 171.8 μm at 10 years. There were no significant changes in the ECD and IOP at any timepoint. Lens opacities developed in 21 eyes (12.1%) during the 10-year follow-up. The mean vault in the lens opacity group was significantly lower than in the clear lens group after 4 years. No patient who had ICL implantation when they were 30 years or younger developed lens opacity or required phacoemulsification. The results indicate that ICL implantation provided long-term stability and good refractive outcomes. Performing this surgery in young patients, especially those 30 years or younger, may be safe in terms of long-term cataract formation.

11 October 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CYChan Min Yang
Chan Min Yang
DLDong Hui Lim
Dong Hui Lim
HKHyo Jeong Kim
Hyo Jeong Kim
TCTae-Young Chung
Tae-Young Chung
To compare biometry and prediction of postoperative refractive outcomes obtained by two swept-source optical coherence tomography (SS-OCT) biometers (IOLMaster 700 and Argos), and a partial coherence interferometry (IOLMaster ver 5.4) Biometric values were measured using two SS-OCT and PCI device and evaluated against one another. Predictive errors were compared at one month after cataract surgery. One hundred forty six eyes were considered. Axial length (AXL) measurements were not successful in 3 eyes measured by IOLMaster 700 and Argos devices, and in 17 eyes measured by IOLMaster ver. 5.4 devices. AXL as measured by Argos showed a tendency to be shorter in long eyes with AXL more than 26.0 mm (p < .001) and to be longer in short eyes with AXL less than 22.5 mm (p = .005). Anterior chamber depth as measured by IOLMaster ver. 5.4 was longer than that measured by the other two SS-OCT devices (vs. IOLMaster 700: p = .003; vs. Argos: p = .006). White-to-white diameter measured using Argos was significantly different measurements obtained using two IOLMaster (p < .001, respectively). The mean absolute postoperative prediction errors were 0.41 ± 0.31 diopters (D), 0.42 ± 0.32 D, and 0.35 ± 0.30 D for IOLMaster ver. 5.4, IOLMaster 700, and Argos, respectively. The ocular biometric measurements using three devices showed high agreement. AXL measured by Argos showed a significant difference compared with the measurements from two IOLMaster. ACD was highly correlated between two SS-OCT devices except IOLMaster ver 5.4. LT and CCT values between IOLMaster 700 and Argos were different significantly. SS-OCT devices demonstrated a superior ability to successfully perform measurements compared with PCI device.

1 May 2009 in Journal of Refractive Surgery
Verified
Journal Article
Closed access
PDF file
SPSung Chul Park
Sung Chul Park
YKYoung Kyo Kwun
Young Kyo Kwun
ECEui-Sang Chung
Eui-Sang Chung
KAKyeon Ahn
Kyeon Ahn
TCTae-Young Chung
Tae-Young Chung
Purpose: To evaluate the efficacy, safety, and rotational and footplate stability of the STAAR Toric Implantable Collamer Lens (TICL; STAAR Surgical Co) for correction of myopic astigmatism. Methods: In this prospective, consecutive, interventional case series, a TICL was implanted uneventfully in 30 consecutive eyes of 20 patients with myopia and astigmatism. The uncorrected visual acuity, best spectacle-corrected visual acuity, refraction, and astigmatism were measured preoperatively and at last follow-up. To evaluate postoperative axis deviation from the intended axis and footplate displacement, a digital anterior segment photograph was taken after full mydriasis and ultrasound biomicroscopy for the four footplates of the TICL in each eye at last follow-up. Possible risk factors for TICL rotation were analyzed through correlation analysis. Results: After mean follow-up of 7.6 months, the mean refractive astigmatism decreased from 2.43±1.24 diopters (D) preoperatively to 0.73±0.47 D postoperatively, and the mean difference between intended and achieved TICL axes was 4.03±3.39°. The absolute value of TICL rotation had significant correlation with the spherical power of the TICL ( P =.037). The footplates of all TICLs were in situ in the ciliary sulcus except for one case in which one of the four footplates was located below the ciliary sulcus. Conclusions: Implantation of the STAAR TICL appears to be an effective and safe method for correction of myopic astigmatism. No clinically significant rotation or footplate displacement of the TICLs was detected postoperatively during mean follow-up of 7.6 months. [ J Refract Surg. 2009;25:403–409.]

18 March 2022 in Ophthalmology Science
Verified
Journal Article
Open access
KSKi Young Son
Ki Young Son
JKJongwoo Ko
Jongwoo Ko
EKEunseok Kim
Eunseok Kim
SLSi Young Lee
Si Young Lee
MKMin-Ji Kim
Min-Ji Kim
DLDONG HUI LIM
DONG HUI LIM
To develop and validate an automated deep learning (DL)-based artificial intelligence (AI) platform for diagnosing and grading cataracts using slit-lamp and retroillumination lens photographs based on the Lens Opacities Classification System (LOCS) III. Cross-sectional study in which a convolutional neural network was trained and tested using photographs of slit-lamp and retroillumination lens photographs. One thousand three hundred thirty-five slit-lamp images and 637 retroillumination lens images from 596 patients. Slit-lamp and retroillumination lens photographs were graded by 2 trained graders using LOCS III. Image datasets were labeled and divided into training, validation, and test datasets. We trained and validated AI platforms with 4 key strategies in the AI domain: (1) region detection network for redundant information inside data, (2) data augmentation and transfer learning for the small dataset size problem, (3) generalized cross-entropy loss for dataset bias, and (4) class balanced loss for class imbalance problems. The performance of the AI platform was reinforced with an ensemble of 3 AI algorithms: ResNet18, WideResNet50-2, and ResNext50. Diagnostic and LOCS III-based grading prediction performance of AI platforms. The AI platform showed robust diagnostic performance (area under the receiver operating characteristic curve [AUC], 0.9992 [95% confidence interval (CI), 0.9986–0.9998] and 0.9994 [95% CI, 0.9989–0.9998]; accuracy, 98.82% [95% CI, 97.7%–99.9%] and 98.51% [95% CI, 97.4%–99.6%]) and LOCS III-based grading prediction performance (AUC, 0.9567 [95% CI, 0.9501–0.9633] and 0.9650 [95% CI, 0.9509–0.9792]; accuracy, 91.22% [95% CI, 89.4%–93.0%] and 90.26% [95% CI, 88.6%–91.9%]) for nuclear opalescence (NO) and nuclear color (NC) using slit-lamp photographs, respectively. For cortical opacity (CO) and posterior subcapsular opacity (PSC), the system achieved high diagnostic performance (AUC, 0.9680 [95% CI, 0.9579–0.9781] and 0.9465 [95% CI, 0.9348–0.9582]; accuracy, 96.21% [95% CI, 94.4%–98.0%] and 92.17% [95% CI, 88.6%–95.8%]) and good LOCS III-based grading prediction performance (AUC, 0.9044 [95% CI, 0.8958–0.9129] and 0.9174 [95% CI, 0.9055–0.9295]; accuracy, 91.33% [95% CI, 89.7%–93.0%] and 87.89% [95% CI, 85.6%–90.2%]) using retroillumination images. Our DL-based AI platform successfully yielded accurate and precise detection and grading of NO and NC in 7-level classification and CO and PSC in 6-level classification, overcoming the limitations of medical databases such as few training data or biased label distribution.